(NASDAQ: PRCT) Procept Biorobotics's forecast annual revenue growth rate of 25.2% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.16%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.21%.
Procept Biorobotics's revenue in 2025 is $274,950,000.On average, 15 Wall Street analysts forecast PRCT's revenue for 2025 to be $18,532,331,947, with the lowest PRCT revenue forecast at $17,741,745,225, and the highest PRCT revenue forecast at $19,705,137,583. On average, 15 Wall Street analysts forecast PRCT's revenue for 2026 to be $24,252,819,401, with the lowest PRCT revenue forecast at $22,687,224,021, and the highest PRCT revenue forecast at $25,336,051,172.
In 2027, PRCT is forecast to generate $30,033,393,671 in revenue, with the lowest revenue forecast at $27,201,524,274 and the highest revenue forecast at $32,246,591,404.